Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00417027 · ClinicalTrials.gov registry record · NA
Programmed Intermittent Epidural Bolus Time Interval and Injection Volume
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT00417027 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 190 participants.
The verdict
NCT00417027, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
Studies suggest that administration of maintenance epidural solutions as programmed or automated intermittent boluses, rather than continuous infusions, result in lower bupivacaine consumption, decreased need for manual boluses by the anesthesiologist, and greater patient satisfaction. In this technique, the epidural maintenance dose is administered as a bolus by the infusion pump at regular intervals instead of as a continuous infusion. However, the optimal combination of bolus volume and dosing interval has not been determined. At one end of the spectrum, a small volume and short bolus dose interval will likely behave like a continuous infusion. At the other end of the spectrum, a large volume and long bolus dose interval may lead to an increased incidence of breakthrough pain. The purpose of this randomized, double-blind trial was to determine how manipulation of the programmed intermittent time interval and volume influences total drug use, quality of analgesia, and patient satisfaction during maintenance of labor analgesia. We hypothesized that manipulation of the programmed intermittent bolus time interval and volume during the maintenance of epidural labor analgesia influences total drug use, quality of analgesia and patient satisfaction.
Interventions
- PROCEDURE Programmed Intermittent Epidural Bolus (PIEB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2006-08 |
| Est. Completion | 2009-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00417027
The ClinicalTrials.gov registry entry for NCT00417027 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Programmed Intermittent Epidural Bolus (PIEB) is the first listed.
NCT00417027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00417027 about?
NCT00417027 is a clinical study titled "Programmed Intermittent Epidural Bolus Time Interval and Injection Volume". Studies suggest that administration of maintenance epidural solutions as programmed or automated intermittent boluses, rather than continuous infusions, result in lower bupivacaine consumption, decreased need for manual boluses by the anesthesiologist, and greater patient satisfaction. In this techn...
What is the current status of trial NCT00417027?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2006-08. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00417027?
The interventions under investigation include: Programmed Intermittent Epidural Bolus (PIEB) (PROCEDURE).
Who is sponsoring clinical trial NCT00417027?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.